Dustin L. Williams, Ph.D.
Affiliations: | 2012 | Bioengineering | University of Utah, Salt Lake City, UT |
Area:
Biomedical Engineering, Microbiology BiologyGoogle:
"Dustin Williams"Parents
Sign in to add mentor| Roy Bloebaum | grad student | 2012 | University of Utah | |
| (Preventing biofilm implant-related osteomyelitis using a novel synthetic analog of antimicrobial peptides.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cornish J, Joseph R, Lin JM, et al. (2025) LACTOFERRIN ENHANCES THE ANTIBIOTIC TREATMENT OF STAPHYLOCOCCUS AUREUS IN BONE INFECTION. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire |
| Williams D, Rothberg D, Kay W, et al. (2025) In vivo efficacy of a refillable intrawound drug delivery device in a sheep model of biofilm-compromised open fracture-related infection. Biofilm. 9: 100262 |
| Gilmore AL, Vu H, Martinez T, et al. (2025) In vitro antibiofilm efficacy of ertapenem, tobramycin, and moxifloxacin against biofilms grown in a glass bead or CDC Biofilm Reactor®. Plos One. 20: e0318487 |
| Somawardana IA, Prasad B, Kay W, et al. (2024) Alternating Magnetic Fields AMF) and Linezolid Reduce Staphylococcus aureus Biofilm in a Large Animal Implant Model. The Journal of Infection. 106271 |
| Gilmore A, Badham M, Rudisin W, et al. (2024) A Bead Biofilm Reactor for High-Throughput Growth and Translational Applications. Microorganisms. 12 |
| Epperson RT, Isaacson BM, Rothberg DL, et al. (2024) Determining Which Combinatorial Combat-Relevant Factors Contribute to Heterotopic Ossification Formation in an Ovine Model. Bioengineering (Basel, Switzerland). 11 |
| Shaw JD, Bailey TL, Ong J, et al. (2023) Development and validation of a large animal ovine model for implant-associated spine infection using biofilm based inocula. Biofilm. 6: 100138 |
| Ong J, Nazarian A, Tam J, et al. (2023) An antimicrobial blue light device to manage infection at the skin-implant interface of percutaneous osseointegrated implants. Plos One. 18: e0290347 |
| Rawson KB, Neuberger T, Smith TB, et al. (2023) comparison of V.A.C.® Granufoam Silver™ and V.A.C.® Granufoam™ loaded with a first-in-class bis-dialkylnorspermidine-terphenyl antibiofilm agent. Biofilm. 6: 100142 |
| Ong J, Godfrey R, Nazarian A, et al. (2023) Comparison of tolerance between antimicrobial blue light, levofloxacin, and rifampin. Frontiers in Microbiology. 14: 1158558 |